• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状血红蛋白的细胞内聚合:疾病严重程度与治疗目标

Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.

作者信息

Noguchi C T, Rodgers G P, Schechter A N

出版信息

Prog Clin Biol Res. 1987;240:381-91.

PMID:3615501
Abstract

We have demonstrated that the extent of intracellular polymerization of deoxyhemoglobin S can be predicted from knowledge of intracellular hemoglobin concentration, composition and oxygen saturation. Furthermore, we have demonstrated that polymer, which appears to be the main determinant of abnormal red cell rheology, can be detected in sickle erythrocytes at high oxygen saturation values and is not significantly affected by membrane and other cellular constituents. Some of the factors which modify the pathophysiology of sickle cell anemia can be classified as genetic or cellular. To analyze in more detail the genetic factors, we examined 12 sickle syndromes. When the effects of these genotype differences are analyzed for their changes in hemoglobin composition and concentration, we found that polymer formation can account for 80% of the variation in hemolytic and clinical severity. Cell heterogeneity can also modify polymer formation. The premature increases in erythrocyte density (intracellular hemoglobin concentration) in sickle cell anemia increases polymerization tendency. Homozygous alpha-thalassemia in sickle cell patients reduces this increase in cell heterogeneity and improves the hemolytic aspect of the sickle cell disease. For homozygous sickle cell patients we find that the broader density distributions (higher degree of cell heterogeneity) are associated with those cell populations with greater tendency of polymer formation. However, the major utility of our knowledge of intracellular polymerization appears to be its value in defining quantitatively the goals of the major therapeutic approaches with respect to how much inhibition of polymerization would be necessary to achieve various levels of amelioration of disease processes. The primary determinant of the amount of polymer formation within the SS erythrocyte is the extent of oxygen saturation. We measured intracellular polymer formation in SS erythrocytes using carbon-13/proton double nuclear magnetic resonance. As the oxygen saturation is decreased below about 90% oxygen saturation, we begin to see the appearance of polymer which steadily increases with decreasing oxygen saturation. The total intracellular hemoglobin concentration also affects the amount of polymer formed. By examining polymer formation in fractionated subpopulations of SS erythrocytes at various density values (or intracellular hemoglobin concentrations) we demonstrated that the polymer fraction increased with increasing intracellular hemoglobin concentration for any given oxygen saturation.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

我们已经证明,脱氧血红蛋白S的细胞内聚合程度可以根据细胞内血红蛋白浓度、组成和氧饱和度来预测。此外,我们还证明,聚合物似乎是异常红细胞流变学的主要决定因素,在高氧饱和度值下可在镰状红细胞中检测到,并且不受膜和其他细胞成分的显著影响。一些改变镰状细胞贫血病理生理学的因素可分为遗传因素或细胞因素。为了更详细地分析遗传因素,我们研究了12种镰状综合征。当分析这些基因型差异对血红蛋白组成和浓度变化的影响时,我们发现聚合物形成可解释80%的溶血和临床严重程度变化。细胞异质性也会改变聚合物形成。镰状细胞贫血中红细胞密度(细胞内血红蛋白浓度)的过早增加会增加聚合倾向。镰状细胞患者的纯合α地中海贫血可减少这种细胞异质性增加,并改善镰状细胞病的溶血方面。对于纯合镰状细胞患者,我们发现更宽的密度分布(更高程度的细胞异质性)与那些具有更大聚合物形成倾向的细胞群体相关。然而,我们对细胞内聚合的了解的主要用途似乎在于其在定量定义主要治疗方法目标方面的价值,即就实现疾病过程的各种改善水平而言,需要多少聚合抑制。SS红细胞内聚合物形成量的主要决定因素是氧饱和度。我们使用碳-13/质子双核磁共振测量SS红细胞内的聚合物形成。当氧饱和度降至约90%以下时,我们开始看到聚合物的出现,其随着氧饱和度的降低而稳步增加。细胞内总血红蛋白浓度也会影响形成的聚合物量。通过检查不同密度值(或细胞内血红蛋白浓度)的SS红细胞分级亚群中的聚合物形成,我们证明,对于任何给定的氧饱和度,聚合物分数随细胞内血红蛋白浓度的增加而增加。(摘要截短于400字)

相似文献

1
Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.镰状血红蛋白的细胞内聚合:疾病严重程度与治疗目标
Prog Clin Biol Res. 1987;240:381-91.
2
Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.镰状血红蛋白的细胞内聚合。细胞异质性的影响。
J Clin Invest. 1983 Sep;72(3):846-52. doi: 10.1172/JCI111055.
3
Determination of sickle hemoglobin polymer in SS and AS erythrocytes.SS型和AS型红细胞中镰状血红蛋白聚合物的测定。
Blood Cells. 1982;8(2):225-35.
4
Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.镰状红细胞内聚合物形成的不均匀性:与溶血性贫血严重程度的可能关联。
Am J Pediatr Hematol Oncol. 1984 Spring;6(1):46-50.
5
Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.在动脉血氧饱和度下镰状细胞血红蛋白的聚合会损害红细胞的可变形性。
J Clin Invest. 1988 Jun;81(6):1669-74. doi: 10.1172/JCI113504.
6
Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.体外二氧化碳和pH值变化对镰状细胞贫血患者血液呼吸功能、红细胞体积、跨膜pH梯度及镰变的影响。
J Lab Clin Med. 1984 Aug;104(2):146-59.
7
Electron microscopic studies of the intracellular polymerization of sickle hemoglobin.镰状血红蛋白细胞内聚合的电子显微镜研究。
Blood Cells. 1988;13(3):359-76.
8
Overview of pathophysiology and rationale for treatment of sickle cell anemia.镰状细胞贫血的病理生理学概述及治疗原理
Semin Hematol. 1997 Jul;34(3 Suppl 3):2-7.
9
Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.α地中海贫血改变镰状细胞病中的红细胞异质性。
J Clin Invest. 1985 May;75(5):1632-7. doi: 10.1172/JCI111870.
10
Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait.α地中海贫血和镰状细胞聚合倾向对镰状细胞性状个体尿浓缩缺陷的影响。
J Clin Invest. 1991 Dec;88(6):1963-8. doi: 10.1172/JCI115521.

引用本文的文献

1
Sickle cell disease: progress towards combination drug therapy.镰状细胞病:联合药物治疗的进展。
Br J Haematol. 2021 Jul;194(2):240-251. doi: 10.1111/bjh.17312. Epub 2021 Jan 20.
2
Sickle cell vasoocclusion: many issues and some answers.镰状细胞血管阻塞:诸多问题与一些答案
Experientia. 1993 Jan 15;49(1):5-15. doi: 10.1007/BF01928783.